Pine Valley Investments Ltd Liability Co Reduces Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Pine Valley Investments Ltd Liability Co reduced its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 35.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 4,386 shares of the biotechnology company’s stock after selling 2,413 shares during the period. Pine Valley Investments Ltd Liability Co’s holdings in Axon Enterprise were worth $2,607,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Asset Dedication LLC increased its holdings in Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares in the last quarter. Insigneo Advisory Services LLC grew its holdings in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC grew its holdings in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AXON has been the subject of a number of recent research reports. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $561.31.

Axon Enterprise Trading Down 0.6 %

Shares of AXON stock opened at $496.65 on Wednesday. The stock has a market cap of $37.87 billion, a price-to-earnings ratio of 128.33, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $265.32 and a fifty-two week high of $715.99. The firm’s 50 day moving average price is $614.17 and its two-hundred day moving average price is $521.71.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the transaction, the president now directly owns 181,892 shares of the company’s stock, valued at $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock valued at $5,631,561 over the last ninety days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.